RE: SP movement18 Nov 2020 17:26
Personally it is interesting to read a variety of opinions.
I think it was me that frickd was having a pop at, though I didn't say hundreds of millions based on Stonechecker alone. What I wrote was:
"Back in 2017 I calculated a plausible market cap of £150M based on successful execution of the Stonechecker (kidney stone imaging) rollout alone:
"The cost of a single lithotripsy treatment is around £750 in India or the
Philipines. If we adopt this as an average global cost, assume a potential population with
access to treatment of 3 billion people, and assume that StoneChecker is licensed for use on
a single patient by StoneChecker Software Ltd for 0.1% of the cost of a single lithotripsy
treatment, this indicates an annual revenue stream of £18M. Software companies have
relatively fixed costs, so the overwhelming majority of this revenue should become net
income. If we assume a price-earnings ratio of 10, this implies a market cap around £150M
once StoneChecker is widely adopted."
I think if frickd disagrees with my conclusion frickd should point out which part of the reasoning above is wrong.
I am pretty sure hasiba's buy was real as I saw it on the reported trades.
DYOR obvs.